Cannabidiol, the non-psychoactive compound in marijuana, may soon be used to treat patients suffering from colon cancer.

Researchers affiliated with British-based GW Pharmaceuticals, a drug company specializing in producing cannabis-based medicine, say that while the world of science has been privy for sometime to the positive effects cannabidiol has on many types of cancer, a new study now shows that CBD is capable of diminishing the progression of colon cancer.

According to the study, which was published in a recent issue of the journal Phytomedicine, scientists were successfully able to slow down tumor growth in laboratory animals with colon cancer by injecting them with a CBD-rich cannabis extract. Unlike many treatment options currently available, cannabidiol not only caused a reduction in pre-cancerous lesions and tumor growth, but it did so without attacking healthy cells.

“In conclusion, we have shown that CBD BDS (botanical drug substance) exerts beneficial actions in experimental models of colon cancer and antiproliferative CB1 and CB2 mediated effects in colorectal cancer cells,” according to the study.

Researchers say they feel confident that the findings will pave the way for colon cancer treatments that are more effective and far less toxic than current methods. With federal law currently prohibiting marijuana in the United States, it is anyone’s guess as to how long it will be before the medical community is permitted to research and develop cannabis-based cancer treatments in the US.

Unfortunately, time is running out for those requiring effective treatments to stay alive: in 2008 alone, there were over 1 million individuals diagnosed with colon cancer worldwide, which led to the untimely demise of more than 600,000 people.

Mike Adams writes for stoners and smut enthusiasts in HIGH TIMES, Playboy’s The Smoking Jacket and Hustler Magazine. You can follow him on Twitter @adamssoup and on Facebook/mikeadams73.